Clinical Research: Response Markers and Mechanisms

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 19 total displayed.

Most recent content

Review
Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer

Vincent O. Dezentjé, Henk-Jan Guchelaar, Johan W.R. Nortier, Cornelis J.H. van de Velde, and Hans Gelderblom
Clin. Cancer Res. 2009; 15: 15-21. [Abstract] [Full text] [PDF]  

Past content

CCR Focus
Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status

Montserrat Garcia-Closas and Stephen Chanock
Clin. Cancer Res. 2008; 14: 8000-8009. [Abstract] [Full text] [PDF]  

CCR Focus
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer

Mitch Dowsett and Anita K. Dunbier
Clin. Cancer Res. 2008; 14: 8019-8026. [Abstract] [Full text] [PDF]  

CCR Focus
Validation of Analytic Methods for Biomarkers Used in Drug Development

Cindy H. Chau, Olivier Rixe, Howard McLeod, and William D. Figg
Clin. Cancer Res. 2008; 14: 5967-5976. [Abstract] [Full text] [PDF]  

CCR Special Focus
Translational Research Working Group Developmental Pathway for Biospecimen-Based Assessment Modalities

Sudhir Srivastava, Joe W. Gray, Brian J. Reid, Oren Grad, Addison Greenwood, Ernest T. Hawk for the Translational Research Working Group
Clin. Cancer Res. 2008; 14: 5672-5677. [Abstract] [Full text] [PDF]  

Subject Reviews
Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective

Chih-Pin Chuu, Rou-Yu Chen, John L. Barkinge, Mark F. Ciaccio, and Richard B. Jones
Mol. Cancer Res. 2008; 6: 885-891. [Abstract] [Full text] [PDF]  

Reviews
Identifying Breast Cancer Druggable Oncogenic Alterations: Lessons Learned and Future Targeted Options

Alberto Ocaña and Atanasio Pandiella
Clin. Cancer Res. 2008; 14: 961-970. [Abstract] [Full text] [PDF]  

CCR Focus
Is Cell Death a Critical End Point for Anticancer Therapies or Is Cytostasis Sufficient?

Olivier Rixe and Tito Fojo
Clin. Cancer Res. 2007; 13: 7280-7287. [Abstract] [Full text] [PDF]  

Reviews
Emerging Roles of MUC4 in Cancer: A Novel Target for Diagnosis and Therapy

Ajay P. Singh, Pallavi Chaturvedi, and Surinder K. Batra
Cancer Res. 2007; 67: 433-436. [Abstract] [Full text] [PDF]  

Review
Spindle checkpoint function and cellular sensitivity to antimitotic drugs

Hiroshi Y. Yamada and Gary J. Gorbsky
Mol. Cancer Ther. 2006; 5: 2963-2969. [Full text] [PDF]  

[Next page] Pages: 1 2